Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

44.77
BATS BZX Real-Time Price
As of 1:27pm ET
 +0.07 / +0.16%
Today’s Change
36.76
Today|||52-Week Range
45.84
+16.56%
Year-to-Date
Abbott Sells More Mylan Holdings
Mar 24 / GuruFocus News - Paid Partner Content
Can Abbott Outperform Despite Alere?
Mar 22 / TheStreet.com - Paid Partner Content
Mylan Hit After Abbott Dumps Shares
Mar 24 / TheStreet.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Can the Repeal of the Fiduciary Rule Harm Your Annuities Investments?
Mar 24 / TheStreet.com - Paid Partner Content
Abbott Laboratories' MitraClip Outcome Positive for DMR
Mar 20 / Zacks.com - Paid Partner Content
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close44.70
Today’s open44.56
Day’s range44.37 - 44.81
Volume191,315
Average volume (3 months)8,621,788
Market cap$77.2B
Dividend yield2.37%
Data as of 1:27pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+11.38%
Earnings growth (next 5 years)+10.65%
Revenue growth (last year)+2.20%
P/E ratio63.0
Price/Sales2.73
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.02-0.06%
AGNAllergan+1.78+0.74%
NVONovo Nordisk+0.08+0.23%
BMYBristol-Myers Squibb+0.07+0.12%
Data as of 1:27pm ET, 03/29/2017

Financials

Next reporting dateApril 19, 2017
EPS forecast (this quarter)$0.43
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts


Search for Jobs